Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
1.
Oncol Rep ; 16(5): 965-70, 2006 Nov.
Article in English | MEDLINE | ID: mdl-17016578

ABSTRACT

We performed a sequential endoscopic examination of esophageal carcinogenesis induced by N-nitrosomethyl-benzylamine (NMBA) in F344 rats. The endoscopic findings were consistent with the histological changes observed in the specimens obtained by a biopsy and/or an autopsy. Seven-week-old male F344 rats received a weekly subcutaneous injection of 0.5 mg/kg NMBA for 15 weeks. The first endoscopic change that was detected was redness of the musosa due to the dilatation of the submucosal blood vessels. Subsequently, the mucosal redness became obscure, and we observed a focal loss of the visible blood vessel network due to hyperkeratosis, followed by the appearance of plaque-like elevated lesions due to acanthosis. Then, smooth and irregular polyps appeared as a result of the development of papilloma without or with dysplastic potential, respectively. Finally, rough elevation appeared as a result of carcinoma in situ and invasive squamous cell carcinoma. The present endoscopic findings correlated closely with the histological changes, indicating that sequential fiberscopic examination may be useful for monitoring esophageal carcinogenesis.


Subject(s)
Carcinogens , Carcinoma, Squamous Cell/chemically induced , Carcinoma, Squamous Cell/pathology , Dimethylnitrosamine/analogs & derivatives , Esophageal Neoplasms/chemically induced , Esophageal Neoplasms/pathology , Animals , Endoscopy/methods , Male , Rats , Rats, Inbred F344
2.
Life Sci ; 75(17): 2091-102, 2004 Sep 10.
Article in English | MEDLINE | ID: mdl-15312753

ABSTRACT

Recent reports indicate that epidermal growth factor (EGF) plays a crucial role for graft adaptation in rat model of small bowel transplantation (SBT). The administration of EGF enhances intestinal cell proliferating rate and the recovery of mucosal structure. However, the effect of EGF on biological functions including glucose absorption in intestinal graft remains to be elucidated. SBT was performed in the two-step procedure. On the first step, intestinal graft (30-cm jejunum) from Brown Norway rats was exteriorized through abdominal wall as a Thiry-Vella loop in recipient Lewis rats for one week. On the second surgery (POD 7), recipient jejunum was replaced orthotopically by the graft, and transplanted rats were treated intraperitoneally with EGF or its vehicle for 3 days. Analyses of histology and biological functions in the graft were done at POD 14. EGF increased both levels of villus height and crypt depth in the graft of transplanted groups. EGF enhanced the glucose absorption as well as the induction of sodium glucose cotransporter 2- to 3-fold in transplanted groups. Further, EGF stimulated the activities of disaccharidase (maltase and sucrase) and the induction of dipeptide cotransporter. These results demonstrate that EGF enhances the structural and functional adaptation of intestinal grafts after SBT. EGF may be useful therapy for patients following intestinal transplantation.


Subject(s)
Adaptation, Physiological/drug effects , Epidermal Growth Factor/pharmacology , Graft Survival/drug effects , Intestine, Small/transplantation , Animals , Blotting, Western , Body Weight , Disaccharides/metabolism , Glucose/metabolism , Intestine, Small/drug effects , Membrane Glycoproteins/metabolism , Monosaccharide Transport Proteins/metabolism , Rats , Rats, Inbred Lew , Sodium-Glucose Transporter 1 , Statistics, Nonparametric
3.
Gan To Kagaku Ryoho ; 31(3): 367-72, 2004 Mar.
Article in Japanese | MEDLINE | ID: mdl-15045942

ABSTRACT

In order to establish the most appropriate protocol of adjuvant chemotherapy for colorectal cancers, several cooperative studies have been undertaken by the Kinki Cooperative Study Group of Chemotherapy for Colorectal Carcinoma (KCSGCCC). In the No. 3 protocol of KCSGCCC, several cancer-associated molecular markers were analyzed to investigate a possible correlation with chemosensitivity and/or patient's prognosis. Here, we report the preliminary results of the analysis of microsatellite instability (MSI) and p53 LOH in 559 cases of Stage II, III colorectal cancer. The MSI was detected in 51 cases (9%) and was shown to have a significant correlation with right-sided localization and histology (poorly differentiated, mucinous). p53 LOH was positive in 225 cases (40%) and was shown to have a significant correlation with left-sided localization and histology (well to moderately differentiated). These results might support the concept of 2 distinct pathways of colorectal carcinogenesis, e.g., RER pathway and LOH pathway.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Colonic Neoplasms/drug therapy , Fluorouracil/analogs & derivatives , Genes, p53 , Loss of Heterozygosity , Microsatellite Repeats , Rectal Neoplasms/drug therapy , Chemotherapy, Adjuvant , Colonic Neoplasms/genetics , Colonic Neoplasms/surgery , Drug Administration Schedule , Female , Fluorouracil/administration & dosage , Humans , Male , Prognosis , Rectal Neoplasms/genetics , Rectal Neoplasms/surgery
4.
Cancer Sci ; 95(2): 131-5, 2004 Feb.
Article in English | MEDLINE | ID: mdl-14965362

ABSTRACT

The present study was directed towards the identification of novel factors involved in the transformation process leading to the formation of gastric cancer. A cDNA library from human gastric cancer cells was constructed using a retroviral vector. Functional cloning was performed by screening for transformation activity in transduced NIH3T3 cells. Six cDNA clones were isolated, including one encoding the elongation factor 1alpha subunit, which was already known to play a role in tumorigenesis. One cDNA (clone 56.2), which was repeatedly isolated during the course of screening, encoded a protein identical to a G-protein-coupled receptor protein, GPR35. In addition, another cDNA clone (72.3) was found to be an alternatively spliced product of the GPR35 gene, whereby 31 amino acids were added to the N-terminus of GPR35. Hence, the proteins encoded by clones 56.2 and 72.3 were designated GPR35a and GPR35b, respectively. RT-PCR experiments revealed that GPR35 gene expression is low or absent in surrounding non-cancerous regions, while both mRNAs were present in all of the gastric cancers examined. The level of 72.3-encoded mRNA was consistently significantly higher than that of 56.2 encoded mRNA. An expression pattern similar to that observed in gastric cancers was detected in normal intestinal mucosa. Based on the apparent transformation activities of the two GPR35 clones in NIH3T3 cells, and the marked up-regulation of their expression levels in cancer tissues, it is speculated that these two novel isoforms of GPR35 are involved in the course of gastric cancer formation.


Subject(s)
Gene Expression Regulation, Neoplastic , Protein Isoforms/genetics , Receptors, G-Protein-Coupled/genetics , Stomach Neoplasms/genetics , Amino Acid Sequence , Animals , Cloning, Molecular , Gene Library , Humans , Intestinal Mucosa/metabolism , Mice , Molecular Sequence Data , NIH 3T3 Cells , Protein Isoforms/biosynthesis , RNA, Messenger/analysis , Receptors, G-Protein-Coupled/biosynthesis , Reverse Transcriptase Polymerase Chain Reaction , Stomach Neoplasms/metabolism , Transduction, Genetic , Transformation, Genetic
5.
Dis Colon Rectum ; 45(9): 1249-54, 2002 Sep.
Article in English | MEDLINE | ID: mdl-12352244

ABSTRACT

PURPOSE: In North America and other high-risk areas, there has been a proximal shift in the subsite distribution of colorectal cancer. We wanted to determine whether any similar change has occurred in Japan, and where the incidence of this disease has increased sharply. METHODS: Data from the Reports of the Japanese Society for Cancer of the Colon and Rectum were used to analyze the time trend of colorectal cancer in Japan between 1974 and 1994 according to the patients' age at diagnosis and sex, and the site of the tumor within the colon or rectum. RESULTS: The percentage of patients over the age of 70, especially females, increased. The increase in the percentage of right-sided colon cancer in colorectal cancer cases was accompanied by a continuous decline in the percentage of rectal cancer in both sexes at all ages. In general, the percentage of right-sided colon cancer in colon cancer cases was stable in men, but increased in women. The rate among patients older than 70 years increased in men, but predominated and remained stable in women. No proximal shift in colon cancer was found in either sex under the age of 69. CONCLUSION: These findings indicated that a proximal shift in the subsite distribution of colorectal cancer has occurred in Japan. This rightward shift of colorectal cancer is due to the decreasing proportion of rectal cancer. Furthermore, the increasing proportion of older patients, especially females, may be another major determinant of the changing colon cancer subsite distribution.


Subject(s)
Colorectal Neoplasms/epidemiology , Colorectal Neoplasms/pathology , Aged , Female , Humans , Incidence , Japan/epidemiology , Male , Middle Aged , Registries
6.
Breast Cancer Res Treat ; 72(1): 1-10, 2002 Mar.
Article in English | MEDLINE | ID: mdl-12000216

ABSTRACT

The effects of cPrG x HCl and epirubicin on the suppression of cell growth were examined on human breast cancer cell line (MDA-MB-231). Either cPrG x HCl or epirubicin alone showed a tumor growth inhibition in a time- and dose-dependent manner, however, the combinatory use of cPrG x HCl together with epirubicin resulted in prominent synergistic effects on the breast cancer cells. In the in vitro studies, the combinatory use of these two drugs accelerated apoptotic cell death as revealed by morphological changes as well as by the appearance of subG1 population by flow cytometry. In addition, confocal microscopy revealed that the accumulation of epirubicin in nucleus increased apparently when cPrG x HCl were present. In the in vivo assay, nude mice bearing xenografted tumor cells received 4 weeks of intraperitoneal administration of cPrG-HCl and epirubicin. After 12 days, the combinatory treatment significantly suppressed the tumor growth compared to the controls. The TUNEL staining revealed that tumor cells in cPrG x HCl plus epirubicin-treated mice exhibited a higher apoptotic rate. In addition, 31P-NMR studies on the xenografted tumor revealed that cPrG x HCl lowered tumor pHi (below pH 6.9). while it did not affected muscle pHi. No pathological changes were observed in any intrinsic organs and the serum alanine aminotransferase levels remained within normal limits among the groups. These results suggest that the combinatory use of cPrG x HCl and epirubicin may be useful for breast cancer therapy.


Subject(s)
Antibiotics, Antineoplastic/pharmacology , Cell Division/drug effects , Epirubicin/pharmacology , Indoles/pharmacology , Pyrroles/pharmacology , Animals , Antibiotics, Antineoplastic/administration & dosage , Antibiotics, Antineoplastic/therapeutic use , Apoptosis , Breast Neoplasms/drug therapy , Dose-Response Relationship, Drug , Drug Synergism , Epirubicin/administration & dosage , Epirubicin/therapeutic use , Female , Flow Cytometry , Humans , In Situ Nick-End Labeling , Indoles/administration & dosage , Indoles/therapeutic use , Injections, Intraperitoneal , Magnetic Resonance Spectroscopy , Mice , Mice, Nude , Microscopy, Confocal , Phosphorus Radioisotopes , Pyrroles/administration & dosage , Pyrroles/therapeutic use , Transplantation, Heterologous , Tumor Cells, Cultured/drug effects
7.
Transplantation ; 73(4): 512-8, 2002 Feb 27.
Article in English | MEDLINE | ID: mdl-11889421

ABSTRACT

BACKGROUND: We have established a new method for the transplantation of allogeneic pancreatic islets (PIs) using sublethal irradiation (9 Gy) plus simultaneous transplantation of PIs and bone marrow cells (BMCs) via the portal vein (PV) followed by intravenous (i.v.) injection of donor BMCs (9 Gy + PV + i.v.). METHODS: Approximately 600 PIs of Brown Norway (BN: RT1An, RT1Bn) rats were transplanted into the liver of streptozotocin-induced diabetic Fischer 344 (F344: RT1Al, RT1Bl) rats via the PV. BMCs (3x108) of BN rats were injected via the PV or i.v. into the recipients simultaneously. In some groups, additional i.v. injections of BMCs from BN rats were given 5 days after the PI transplantation. RESULTS: All the recipients (10 of 10) in the 9 Gy + PV + i.v. group showed normoglycemia for more than 1 year, whereas PIs were rejected within 30 days after transplantation in the group of 9 Gy + i.v. + i.v. CONCLUSIONS: These results suggest that simultaneous transplantation of PIs and BMCs via the PV is effective in inducing persistent tolerance.


Subject(s)
Bone Marrow Transplantation/physiology , Diabetes Mellitus, Experimental/surgery , Graft Survival/physiology , Islets of Langerhans Transplantation/physiology , Animals , Blood Glucose/metabolism , Bone Marrow Transplantation/methods , Female , Flow Cytometry , Graft Rejection/pathology , Graft Survival/immunology , Immunosuppression Therapy/methods , Islets of Langerhans Transplantation/immunology , Islets of Langerhans Transplantation/pathology , Lymphocyte Culture Test, Mixed , Male , Portal Vein , Rats , Rats, Inbred BN , Rats, Inbred F344 , T-Lymphocytes, Cytotoxic , Time Factors
8.
Life Sci ; 70(7): 809-19, 2002 Jan 04.
Article in English | MEDLINE | ID: mdl-11833743

ABSTRACT

We reported that epidermal growth factor (EGF) stimulated graft adaptation in a rat model of syngeneic small bowel transplantation. However, graft rejection is a severe problem with clinical small bowel transplantation, because small intestinal wall contains large amounts of lymphoid tissue. Studies were performed to investigate the effect of EGF on allogeneic graft adaptation after small bowel transplantation in rats treated with an immunosuppressant FK506. The transplanted animals received intraperitoneally EGF or saline (untreated) after surgery and were examined for analysis one week later. EGF-treated group markedly enhanced the water absorption and induction of sodium glucose cotransporter (SGLTI) as compared with EGF-untreated group. EGF-treated group also increased the mucosal crypt depth and its cell proliferating rate, although there was no significant difference in the mucosal villus height between the two groups. These results indicate that EGF accelerates intestinal allograft adaptation in part by the recovery of mucosal structure and function after small bowel transplantation in rats. EGF may have relevance to promote graft function in clinical small intestinal transplantation.


Subject(s)
Adaptation, Physiological/drug effects , Epidermal Growth Factor/pharmacology , Graft Survival/drug effects , Jejunum/transplantation , Animals , Blotting, Western , Drug Interactions , Graft Rejection/drug therapy , Immunosuppressive Agents/therapeutic use , Intestinal Absorption/drug effects , Jejunum/pathology , Jejunum/physiopathology , Male , Membrane Glycoproteins/analysis , Membrane Glycoproteins/biosynthesis , Monosaccharide Transport Proteins/analysis , Monosaccharide Transport Proteins/biosynthesis , Organ Transplantation , Rats , Rats, Inbred BN , Sodium-Glucose Transporter 1 , Tacrolimus/therapeutic use , Transplantation, Isogeneic
9.
Ann Surg Oncol ; 9(1): 27-34, 2002.
Article in English | MEDLINE | ID: mdl-11829427

ABSTRACT

BACKGROUND: The need for a precise lymph node staging without stage migration is of paramount importance when comparing and evaluating international treatment results. METHODS: We reviewed 1019 patients who underwent R0 resection at Kansai Medical University between 1980 and 1997. The patients were classified according to the 1997 International Union Against Cancer (UICC)/American Joint Committee on Cancer (AJCC) pN classification or the N staging depending on the ratio between the number of excised and the number of involved lymph nodes (pN1, < or = 25%; pN2, < or = 50%; pN3, >50%). RESULTS: Among the 1997 UICC/AJCC pN subgroups, prognosis worsened with an increase in lymph node ratio. In contrast, the ratio-based classification showed more homogenous survival according to the number of involved lymph nodes. Multiple stepwise regression analysis showed that the ratio-based classification was the most significant prognostic factor, whereas the 1997 UICC/AJCC classification was not found to be an independent predictor of survival. In addition, the ratio-based classification showed a superiority to the 1997 UICC/AJCC classification with respect to stage migration. CONCLUSIONS: Ratio-based lymph node staging is simple and gives more precise information for prognosis with fewer problems related to stage migration than the 1997 UICC/AJCC staging system.


Subject(s)
Stomach Neoplasms/pathology , Adult , Aged , Female , Humans , Lymphatic Metastasis , Male , Middle Aged , Multivariate Analysis , Neoplasm Staging , Prognosis , Retrospective Studies , Stomach Neoplasms/classification , Survival Analysis
SELECTION OF CITATIONS
SEARCH DETAIL
...